Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults ; volume:62 ; number:2 ; day:2 ; month:2 ; year:2023 ; pages:321-333 ; date:2.2023
Clinical pharmacokinetics ; 62, Heft 2 (2.2.2023), 321-333, 2.2023
- Urheber
-
Boettcher, Michael
Nowotny, Bettina
Krausche, Robert
Becker, Corina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-022-01203-5
- URN
-
urn:nbn:de:101:1-2023090713220094090710
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boettcher, Michael
- Nowotny, Bettina
- Krausche, Robert
- Becker, Corina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Authors’ Reply to Ganijee et al.: “Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults”
Pharmacokinetics and Pharmacodynamics of Posaconazole
Journal of pharmacokinetics and pharmacodynamics
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
Pharmacokinetics and Pharmacodynamics of Tedizolid
Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
Authors’ Reply to Ganijee et al.: “Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults”
Pharmacokinetics and Pharmacodynamics of Posaconazole
Journal of pharmacokinetics and pharmacodynamics
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
Pharmacokinetics and Pharmacodynamics of Tedizolid
Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin
Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
Authors’ Reply to Ganijee et al.: “Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults”
Pharmacokinetics and Pharmacodynamics of Posaconazole
Journal of pharmacokinetics and pharmacodynamics
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
Pharmacokinetics and Pharmacodynamics of Tedizolid
Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist
Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin